ArticleJournal of pharmaceutical health care and sciences2026
Risk modifiers of immune-related adverse events in patients with NSCLC undergoing immunotherapy: a retrospective cohort study.
Takashi Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.